Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kuangxiong aerosol for coronary microvascular disease symptoms and quality of life
ChiCTR2100046583Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jun 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial of kuanxiong aerosol in Coronary Small Vessel Disease (CMD) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Change in Seattle Angina Questionnaire score. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
kuanxiong aerosol
03
Conditions
Coronary Small Vessel Disease (CMD)
Beyond the preview
Go deeper on ChiCTR2100046583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100046583.